timolol has been researched along with Meibomian Gland Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YJ; Jun, I; Kim, BR; Kim, TI; Seo, KY | 1 |
| Jung, JH; Kim, SI; Lee, JE; Lee, SM; Shin, J | 1 |
2 other study(ies) available for timolol and Meibomian Gland Dysfunction
| Article | Year |
|---|---|
Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2.
Topics: Adrenergic beta-Antagonists; Cyclic AMP-Dependent Protein Kinases; Glaucoma; Humans; Lipids; Meibomian Gland Dysfunction; PPAR gamma; Receptors, Adrenergic, beta-2; Signal Transduction; Timolol | 2022 |
Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma.
Topics: Administration, Ophthalmic; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Cross-Sectional Studies; Drug Combinations; Dry Eye Syndromes; Female; Gonioscopy; Humans; Interferometry; Intraocular Pressure; Lipid Metabolism; Low Tension Glaucoma; Male; Meibomian Gland Dysfunction; Middle Aged; Ophthalmic Solutions; Sulfonamides; Tears; Thiophenes; Timolol; Tonometry, Ocular | 2019 |